P/E ratio for Neurones (NRO.PA)
P/E ratio at the end of 2022: 21.6
According to Neurones's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 25.4286. At the end of 2022 the company had a P/E ratio of 21.6.
P/E ratio history for Neurones from 2002 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 21.6 | -6.89% |
| 2021 | 23.1 | 42.97% |
| 2020 | 16.2 | 4.92% |
| 2019 | 15.4 | -6.64% |
| 2018 | 16.5 | -27.66% |
| 2017 | 22.8 | 3.95% |
| 2016 | 22.0 | 14.42% |
| 2015 | 19.2 | 33.35% |
| 2014 | 14.4 | 13.89% |
| 2013 | 12.6 | 18% |
| 2012 | 10.7 | 11.4% |
| 2011 | 9.62 | -0.31% |
| 2010 | 9.65 | 2.88% |
| 2009 | 9.38 | 37.17% |
| 2008 | 6.84 | -42% |
| 2007 | 11.8 | -22.02% |
| 2006 | 15.1 | -23.03% |
| 2005 | 19.6 | 10.67% |
| 2004 | 17.8 | -15.04% |
| 2003 | 20.9 | 56.76% |
| 2002 | 13.3 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.